Discover how DFIN helped PMV Pharma execute a successful IPO followed soon after by a 10-Q and 10-K.
“If we hadn’t had ActiveDisclosure in place, however, I’m not sure how we would have survived at all. We had a third-quarter 10-Q requirement very soon after IPO, and without AD, we would have had to work either through our attorneys or with a paper proofing process that would have been extremely inefficient.”
J.D. KERN
VP & Controller at PMV Pharma
